Pacira appoints four new independent directors to board of directors

Pacira BioSciences (PCRX) announced the appointments of Marcelo Bigal, MD, PhD, Abraham Ceesay, Michael Yang, and Alethia Young, to its Board of Directors effective immediately. Following these director appointments, Pacira will have 12 experienced directors. Dr. Bigal is the President and Chief Executive Officer of Ventus Therapeutics. Ceesay brings nearly two decades of biopharmaceutical industry experience to the Pacira Board of Directors. Yang most recently served as President and Chief Executive Officer of ViaCyte. Young is currently Chief Financial Officer of Bicycle Therapeutics (BCYC)